FIELD: medicine; pharmaceutics.
SUBSTANCE: invention refers to pharmaceutics, namely to using a complex of an angiotensin II receptor antagonist and a neutral endopeptidase (NEP) inhibitor. Disclosed is the use of a complex of an angiotensin II receptor antagonist and a neutral endopeptidase (NEP) inhibitor in the preparation of a drug for use in the treatment of heart failure with a reduced ejection fraction, wherein said complex has the following structural units: (EXP3174⋅AHU377)⋅xCa⋅nH2O, where x is 1.5; and n is value from 0 to 3.
EFFECT: use of the complex described above has specific selectivity with respect to cardiac failure with a reduced ejection fraction.
7 cl, 1 dwg, 4 tbl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOUNDS OF A METABOLITE OF AN ANGIOTENSIN II RECEPTOR ANTAGONIST AND A NEP INHIBITOR, AND METHODS FOR PREPARING THEM | 2017 |
|
RU2723642C1 |
| NEP INHIBITORS FOR TREATMENT OF DISEASES CHARACTERIZED BY ATRIAL ENLARGEMENT OR REMODELING | 2018 |
|
RU2809222C2 |
| NEP INHIBITORS FOR TREATING DISEASES CHARACTERIZED BY ATRIAL ENLARGEMENT OR REMODELING | 2013 |
|
RU2667643C2 |
| TREATMENT OF HYPERTENSION AND/OR PREVENTION AND TREATMENT OF HEART FAILURE IN MAMMAL, RECEIVING ANTICOAGULANT THERAPY | 2011 |
|
RU2564941C2 |
| APPLICATION OF PEPTIDE GGF2 IN TREATMENT OR PREVENTION OF HEART FAILURE IN MAMMALS | 2009 |
|
RU2536938C2 |
| METHOD FOR PREDICTING POSITIVE RESPONSE TO CARDIAC CONTRACTILITY MODULATION THERAPY IN PATIENTS WITH CHRONIC HEART FAILURE WITH REDUCED LEFT VENTRICULAR EJECTION FRACTION AND ATRIAL FIBRILLATION | 2023 |
|
RU2807230C1 |
| METHOD FOR PREDICTION OF RESPONSE TO CARDIAC RESYNCHRONISING THERAPY IN PATIENTS WITH CHRONIC HEART FAILURE | 2018 |
|
RU2716479C1 |
| THERAPEUTIC DOSING OF NEUREGULIN OR ITS SUB-SEQUENCE FOR TREATING OR PREVENTING HEART FAILURE | 2014 |
|
RU2698090C2 |
| MODIFIED RNA ENCODING VEGF-A POLYPEPTIDES, COMPOSITIONS CONTAINING IT, AND THEIR APPLICATION METHODS | 2017 |
|
RU2756313C2 |
| METHODS FOR TREATMENT OF HEART FAILURE AND ISCHEMIC-REPERFUSION INJURY OF HEART | 2017 |
|
RU2767445C2 |
